3/31
10:45 am
tnya
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Medium
Report
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
3/31
10:00 am
tnya
Tenaya Therapeutics Announces Late Breaker Presentation of New Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 at American College of Cardiology Annual Meeting
Medium
Report
Tenaya Therapeutics Announces Late Breaker Presentation of New Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 at American College of Cardiology Annual Meeting
3/24
08:37 am
tnya
Augustine secures $85m to advance Charcot-Marie-Tooth candidate [Yahoo! Finance]
Medium
Report
Augustine secures $85m to advance Charcot-Marie-Tooth candidate [Yahoo! Finance]
3/24
08:30 am
tnya
Tenaya Therapeutics Publishes Preclinical Data Demonstrating TN-201 Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy Models
High
Report
Tenaya Therapeutics Publishes Preclinical Data Demonstrating TN-201 Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy Models
3/21
04:51 pm
tnya
Tenaya Therapeutics, Inc. (TNYA) Stock [Seeking Alpha]
High
Report
Tenaya Therapeutics, Inc. (TNYA) Stock [Seeking Alpha]
3/19
08:30 am
tnya
Tenaya Therapeutics Announces Late Breaker and New Data Presentations at the American College of Cardiology’s Annual Scientific Session
Low
Report
Tenaya Therapeutics Announces Late Breaker and New Data Presentations at the American College of Cardiology’s Annual Scientific Session
3/13
12:36 pm
tnya
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $18.00 to $6.00. They now have a "buy" rating on the stock.
Medium
Report
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $18.00 to $6.00. They now have a "buy" rating on the stock.
3/12
09:12 am
tnya
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its price target lowered by analysts at Morgan Stanley from $15.00 to $5.00. They now have an "overweight" rating on the stock.
Medium
Report
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its price target lowered by analysts at Morgan Stanley from $15.00 to $5.00. They now have an "overweight" rating on the stock.
3/12
08:36 am
tnya
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its price target lowered by analysts at Chardan Capital from $18.00 to $9.00. They now have a "buy" rating on the stock.
Low
Report
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its price target lowered by analysts at Chardan Capital from $18.00 to $9.00. They now have a "buy" rating on the stock.
3/11
08:15 am
tnya
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its price target lowered by analysts at HC Wainwright from $18.00 to $5.00. They now have a "buy" rating on the stock.
Medium
Report
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its price target lowered by analysts at HC Wainwright from $18.00 to $5.00. They now have a "buy" rating on the stock.
3/10
04:16 pm
tnya
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]
3/10
04:05 pm
tnya
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Medium
Report
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
3/3
11:19 pm
tnya
Tenaya Therapeutics Announces Pricing of Public Offering
High
Report
Tenaya Therapeutics Announces Pricing of Public Offering
3/3
04:10 pm
tnya
Tenaya Therapeutics Announces Proposed Public Offering
High
Report
Tenaya Therapeutics Announces Proposed Public Offering
3/3
08:06 am
tnya
Tenaya Therapeutics to Participate in Upcoming March Investor Conferences [Yahoo! Finance]
Medium
Report
Tenaya Therapeutics to Participate in Upcoming March Investor Conferences [Yahoo! Finance]
3/3
08:00 am
tnya
Tenaya Therapeutics to Participate in Upcoming March Investor Conferences
Medium
Report
Tenaya Therapeutics to Participate in Upcoming March Investor Conferences
2/3
12:26 pm
tnya
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Low
Report
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
2/3
09:43 am
tnya
Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for Regenerative Medicine [Yahoo! Finance]
Low
Report
Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for Regenerative Medicine [Yahoo! Finance]
2/3
08:30 am
tnya
Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for Regenerative Medicine
Low
Report
Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for Regenerative Medicine
1/14
08:02 am
tnya
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Medium
Report
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
1/13
11:54 am
tnya
Tenaya Therapeutics Announces 2025 Strategic Priorities and Anticipated Milestones [Yahoo! Finance]
Low
Report
Tenaya Therapeutics Announces 2025 Strategic Priorities and Anticipated Milestones [Yahoo! Finance]
1/13
09:16 am
tnya
Tenaya Therapeutics Announces 2025 Strategic Priorities and Anticipated Milestones
Medium
Report
Tenaya Therapeutics Announces 2025 Strategic Priorities and Anticipated Milestones